Literature DB >> 20185190

A new role for an old marker, HBsAg.

Maurizia Rossana Brunetto.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20185190     DOI： 10.1016/j.jhep.2009.12.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  25 in total

1.  Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B.

Authors:  B Rossetti; C Bianco; A De Luca
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

2.  Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay.

Authors:  B J Zacher; F Moriconi; S Bowden; R Hammond; S Louisirirotchanakul; P Phisalprapa; T Tanwandee; K Wursthorn; M R Brunetto; H Wedemeyer; F Bonino
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

3.  HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions.

Authors:  Yi-Min Zhang; Yi-Da Yang; Hong-Yu Jia; Lin-Yan Zeng; Wei Yu; Ning Zhou; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.

Authors:  Hua-Bang Zhou; Qiao-Mei Li; Zheng-Rong Zhong; Jing-Yi Hu; Xiao-Lan Jiang; Hao Wang; Hui Wang; Bing Yang; He-Ping Hu
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

5.  Management of hepatitis B in developing countries.

Authors:  Zaigham Abbas; Adeel R Siddiqui
Journal:  World J Hepatol       Date:  2011-12-27

6.  Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.

Authors:  Xiaolei Zhuang; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Altaira D Dearborn; Joni L Trenbeath; Elif Eren; Alasdair C Steven; Christoph Rader; Paul T Wingfield
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

7.  HBsAg Quantification in Clinical Practice.

Authors:  Avnish K Seth
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

8.  Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.

Authors:  Jeyamani Ramachandran; Ashrafali Mohamed Ismail; Gaurav Chawla; Gnanadurai John Fletcher; Ashish Goel; C E Eapen; Priya Abraham
Journal:  Indian J Gastroenterol       Date:  2013-09-20

9.  Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk.

Authors:  Yang Yang; Jing Gao; Yu-Ting Tan; Hong-Lan Li; Jing Wang; Xiao Ma; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  J Gastroenterol Hepatol       Date:  2018-02-05       Impact factor: 4.029

10.  Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy.

Authors:  Miwa Kawanaka; Ken Nishino; Jun Nakamura; Takahito Oka; Noriyo Urata; Daisuke Goto; Mitsuhiko Suehiro; Hirofumi Kawamoto; Masatoshi Kudo; Gotaro Yamada
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.